BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38384234)

  • 1. Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways.
    Faisal SM; Clewner JE; Stack B; Varela ML; Comba A; Abbud G; Motsch S; Castro MG; Lowenstein PR
    Adv Sci (Weinh); 2024 May; 11(18):e2309796. PubMed ID: 38384234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression.
    Comba A; Faisal SM; Dunn PJ; Argento AE; Hollon TC; Al-Holou WN; Varela ML; Zamler DB; Quass GL; Apostolides PF; Abel C; Brown CE; Kish PE; Kahana A; Kleer CG; Motsch S; Castro MG; Lowenstein PR
    Nat Commun; 2022 Jun; 13(1):3606. PubMed ID: 35750880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.
    Xu X; Bao Z; Liu Y; Ji J; Liu N
    Cell Mol Neurobiol; 2017 Nov; 37(8):1359-1371. PubMed ID: 28124208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-organization in brain tumors: How cell morphology and cell density influence glioma pattern formation.
    Jamous S; Comba A; Lowenstein PR; Motsch S
    PLoS Comput Biol; 2020 May; 16(5):e1007611. PubMed ID: 32379821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion.
    Comba A; Dunn PJ; Kish PE; Kadiyala P; Kahana A; Castro MG; Lowenstein PR
    J Vis Exp; 2020 Apr; (158):. PubMed ID: 32338655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
    Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
    Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
    Tan J; Liu M; Zhang JY; Yao YL; Wang YX; Lin Y; Song K; Tan J; Wu JR; Cui YH; Wang Y; Bian XW
    J Pathol; 2018 Jun; 245(2):160-171. PubMed ID: 29473166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
    Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
    Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Role of Matrix gla Protein in Glioma Cell Migration.
    Fu MH; Wang CY; Hsieh YT; Fang KM; Tzeng SF
    Mol Neurobiol; 2018 Jun; 55(6):4624-4636. PubMed ID: 28707070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.
    Niklasson M; Bergström T; Jarvius M; Sundström A; Nyberg F; Haglund C; Larsson R; Westermark B; Segerman B; Segerman A
    J Pathol; 2019 Nov; 249(3):295-307. PubMed ID: 31298733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.
    Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D
    Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
    Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
    Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular pathways facilitating glioma cell invasion in situ.
    Nevo I; Woolard K; Cam M; Li A; Webster JD; Kotliarov Y; Kim HS; Ahn S; Walling J; Kotliarova S; Belova G; Song H; Bailey R; Zhang W; Fine HA
    PLoS One; 2014; 9(11):e111783. PubMed ID: 25365423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
    Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
    Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.